Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Transcutaneous Auricular Neurostimulation as a Treatment for Substance Use Disorder

NCT07281261 is registered in ClinicalTrials.gov with Spark Biomedical, Inc. as lead sponsor.

NCT NCT07281261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07281261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Transcutaneous Auricular Neurostimulation as a Treatment for Substance Use Disorder
Lead sponsor
Spark Biomedical, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
January 28, 2026
Completion date
August 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, alcohol use disorder, substance use disorders, substance use disorders alcohol use withdrawal state